Evidence map›Paper›PMID 30367171›Full record

ArticleScientific reports2018

Single-Stranded Nucleic Acids Regulate TLR3/4/7 Activation through Interference with Clathrin-Mediated Endocytosis.

Peter Järver, Aleksandra Dondalska, Candice Poux, AnnSofi Sandberg, Joseph Bergenstråhle, Annette E Sköld, Nathalie Dereuddre-Bosquet, Fréderic Martinon, Sandra Pålsson, Eman Zaghloul and 9 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. A Non-Coding Oligonucleotide Recruits Cutaneous CD11bAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 4 countries.

Peter JärverDepartment of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, 106 91, Stockholm, Sweden. peter.jarver@su.se.ORCID http://orcid.org/0000-0001-9643-5874
Aleksandra DondalskaDepartment of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, 106 91, Stockholm, Sweden.
Candice PouxDepartment of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, 106 91, Stockholm, Sweden.
AnnSofi SandbergCancer Proteomics Mass Spectrometry, Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, 171 65, Stockholm, Sweden.
Joseph BergenstråhleDepartment of Gene Technology, Science for Life Laboratory, Royal Institute of Technology, 171 65, Solna, Sweden.
Annette E SköldDepartment of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, 106 91, Stockholm, Sweden.
Nathalie Dereuddre-BosquetCEA, -Université Paris Sud-Inserm U1184, IDMIT Department, Institut de Biologie Francois Jacob (IBFJ), 922 60, Fontenay-aux-Roses, France.
Fréderic MartinonCEA, -Université Paris Sud-Inserm U1184, IDMIT Department, Institut de Biologie Francois Jacob (IBFJ), 922 60, Fontenay-aux-Roses, France.
Sandra PålssonDepartment of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, 106 91, Stockholm, Sweden.
Eman ZaghloulClinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, 141 86, Stockholm, Sweden.
David BrodinBioinformatics and Expression Analysis core facility, Department of Biosciences and Nutrition, Karolinska Institutet, 141 83, Stockholm, Sweden.
Birgitta SanderDivision of Pathology, Department of Laboratory Medicine, Karolinska Institutet, 141 86, Stockholm, Sweden.
Kim A LennoxIntegrated DNA Technologies Inc, Coralville, 52241, Iowa, USA.
Mark A BehlkeIntegrated DNA Technologies Inc, Coralville, 52241, Iowa, USA.
Samir El-AndaloussiClinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, 141 86, Stockholm, Sweden.
Janne LehtiöCancer Proteomics Mass Spectrometry, Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, 171 65, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-8100-9562
Joakim LundebergDepartment of Gene Technology, Science for Life Laboratory, Royal Institute of Technology, 171 65, Solna, Sweden.ORCID http://orcid.org/0000-0003-4313-1601
Roger LeGrandCEA, -Université Paris Sud-Inserm U1184, IDMIT Department, Institut de Biologie Francois Jacob (IBFJ), 922 60, Fontenay-aux-Roses, France.
Anna-Lena SpetzDepartment of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, 106 91, Stockholm, Sweden. anna-lena.spetz@su.se.ORCID http://orcid.org/0000-0003-3964-9512
Stockholm University · SEKarolinska Institutet · SEScience for Life Laboratory · SEUniversité Paris-Sud · FRIntegrated DNA Technologies (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recognition of nucleic acids by endosomal Toll-like receptors (TLR) is essential to combat pathogens, but requires strict control to limit inflammatory responses. The mechanisms governing this tight regulation are unclear. We found that single-stranded oligonucleotides (ssON) inhibit endocytic pathways used by cargo destined for TLR3/4/7 signaling endosomes. Both ssDNA and ssRNA conferred the endocytic inhibition, it was concentration dependent, and required a certain ssON length. The ssON-mediated inhibition modulated signaling downstream of TLRs that localized within the affected endosomal pathway. We further show that injection of ssON dampens dsRNA-mediated inflammatory responses in the skin of non-human primates. These studies reveal a regulatory role for extracellular ssON in the endocytic uptake of TLR ligands and provide a mechanistic explanation of their immunomodulation. The identified ssON-mediated interference of endocytosis (SOMIE) is a regulatory process that temporarily dampens TLR3/4/7 signaling, thereby averting excessive immune responses.

Indexed as

AnimalsCells, CulturedChemokinesClathrinCytokinesDNA, Single-StrandedEndocytosisEndosomesHumansLeukocytes, MononuclearMacaca fascicularisOligonucleotidesPoly I-CSignal TransductionSkinToll-Like Receptor 3ChemokinesClathrinCytokinesDNA, Single-StrandedOligonucleotidesPoly I-CToll-Like Receptor 3Toll-Like Receptor 4Toll-Like Receptor 7

Identifiers

PMID30367171
PMCPMC6203749
OpenAlexW2897002724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.